ABILIFY MAINTENA (aripiprazole) is indicated for: Treatment of schizophrenia [see Pharmacology: Pharmacodynamics: CLINICAL STUDIES: Schizophrenia under Actions]; Maintenance monotherapy treatment of bipolar I disorder in adults [see Pharmacology: Pharmacodynamics: CLINICAL STUDIES: Bipolar I Disorder - Maintenance Monotherapy under Actions].